What is the prevalence of autosomal dominant polycystic kidney disease (ADPKD)?

Updated: Mar 24, 2020
  • Author: Roser Torra, MD, PhD; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print

Worldwide, ADPKD affects approximately 4 to 7 million individuals and accounts for 7-15% of patients on renal replacement therapy. [17] In North America and Europe, ADPKD is responsible for 6-10% of ESRD cases. Approximately one per 800-1000 population carries a mutation for this condition. Approximately 85-90% of patients with ADPKD have ADPKD1; most of the remaining patients have ADPKD2. [18]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!